GLUCOSE ISOMERASE FROM STREPTOMYCES OLIVOCHROMOGENES
Glucose isomerase from Streptomyces olivochromogenes is an enzyme preparation used in food processing, especially in the production of high fructose corn syrup, and is affirmed by FDA as GRAS under 21 CFR 184.1372.
What It Is
Glucose isomerase from Streptomyces olivochromogenes is a microbial enzyme preparation classified in food science and regulatory systems as an enzyme that catalyzes the reversible isomerization of sugars, especially converting glucose to fructose. Enzymes like this belong to a class of intramolecular oxidoreductases known specifically by the enzyme commission number EC 5.3.1.5 and are often referred to interchangeably as glucose isomerase or xylose isomerase due to their activity on both glucose and xylose substrates. The name 'Streptomyces olivochromogenes' refers to the bacterial species from which the enzyme is produced under controlled fermentation conditions. This enzyme is used industrially and in food processing for its ability to facilitate sugar conversion reactions that are important in sweetener manufacture. Its use in foods is tied to its technical function rather than as a source of nutritional energy or essential nutrients, with activity defined by its catalytic role in changing sugar configurations. The regulatory code 184.1372 links this specific enzyme preparation to affirmations under U.S. food additive regulations, establishing its identity and accepted use conditions within that system. Glucose isomerase preparations are typically supplied in immobilized or insoluble forms, meaning the enzyme is fixed on carriers or matrices that keep it insoluble during food processing operations. This physical state supports its repeated use in industrial processes such as continuous flow reactors during high fructose corn syrup production. Such preparations are designed to be inert regarding solubility, ensuring that the active enzyme remains associated with a carrier and does not migrate into final food products themselves. The general concept of immobilization also helps maintain enzyme activity over extended use and can enhance operational stability under processing temperatures and conditions. In scientific contexts, glucose isomerases are well characterized for their catalytic mechanism. They facilitate an intramolecular rearrangement of aldose to ketose sugars without requiring the input of high levels of energy. In commercial contexts, they are a workhorse in the sweetener industry given the economic value of converting abundant glucose syrups into sweeter fructose-rich syrups used in a variety of food applications.
How It Is Made
The manufacturing process for glucose isomerase from Streptomyces olivochromogenes typically begins with the controlled fermentation of the microorganism Streptomyces olivochromogenes. In a fermentation vessel, this strain is grown under defined conditions that promote high yields of the target enzyme. During the fermentation, the bacteria produce glucose isomerase extracellularly or within cell biomass, after which downstream processing is used to harvest and concentrate the enzyme. Typical steps in enzyme preparation involve cell separation, enzyme extraction, purification, and in many cases immobilization. Cell separation is commonly achieved through filtration or centrifugation after the fermentation phase. The resulting biomass and supernatant containing the enzyme are then processed to isolate the active protein. Enzyme purification steps may include precipitation, dialysis, chromatographic methods, or membrane filtration to concentrate and refine the enzyme. For industrial use, glucose isomerase is frequently immobilized on a support matrix composed of food-compatible materials to render it insoluble. This immobilization process often employs chemical crosslinkers or carriers that bind the enzyme while maintaining catalytic activity, facilitating reuse in continuous processing equipment. The resulting immobilized enzyme preparation must meet purity and identity specifications typical for enzyme preparations used in food processing, including limits on potential contaminants like residual microbial cells or unwanted byproducts. Regulatory compendia such as the Food Chemicals Codex include general specifications for enzyme preparations, covering acceptable purity and activity parameters. Because glucose isomerase preparations are intended for a technical function rather than direct nutritional contribution, manufacturing focuses on maximizing activity and stability while minimizing substances unrelated to the catalytic role of the enzyme. Enzyme preparations derived from microbial fermentation are common in food processing because they can be produced at scale and with high consistency. The fermentation organism used must be well-characterized and nonpathogenic, with processes validated to prevent the presence of hazardous substances. After fermentation and processing, final testing ensures that the enzyme preparation performs as intended under typical use conditions.
Why It Is Used In Food
Glucose isomerase from Streptomyces olivochromogenes is used in food primarily for its technological ability to convert glucose into fructose. Fructose is sweeter than glucose, making fructose-rich syrups desirable in a range of food products because they can provide the same level of sweetness at lower added usage compared to less sweet syrups. Enzymatic isomerization is a cornerstone of producing high fructose corn syrup and similar fructose-enriched syrups that serve as sweetening agents in beverages, baked goods, sauces, and other processed foods. In commercial food manufacturing, the efficiency and specificity of glucose isomerase support cost-effective production. Chemical methods for sugar modification typically require harsher conditions and may produce unwanted byproducts, whereas enzymatic conversion offers selectivity and lower temperature processing. This enzyme’s catalytic activity operates under conditions compatible with food processing systems and can be integrated into continuous production lines. As a result, food processors can achieve consistent product quality and desired sweetness profiles with predictable performance. The use of specific enzyme preparations in food processing also aligns with broader industrial trends toward biocatalysis. Enzymes like glucose isomerase act on substrates without leaving a residual functional presence in the finished product when used under good manufacturing practice conditions. Instead, their role is confined to catalyzing a transformation reaction during processing, after which the enzyme is typically removed or remains immobilized within production equipment. This characteristic helps food manufacturers meet regulatory expectations about ingredient function and ensures that only intended components appear in final products. Food science and regulatory frameworks distinguish ingredients based on their function in the food system rather than their origin alone. Glucose isomerases exemplify a class of processing aids that enable targeted biochemical transformations without altering the nutritional profile of the end food beyond changes in sugar composition. This catalytic role is precisely why such enzymes are included in direct food substance regulations in certain jurisdictions when their use meets conditions of safety and good manufacturing practice.
Adi Example Calculation
When a numeric acceptable daily intake (ADI) is not specified for an enzyme preparation such as glucose isomerase from Streptomyces olivochromogenes, illustrative calculations of daily intake are not directly applicable in the same way they are for chemical additives with defined ADIs. In regulatory terms, the lack of a numeric ADI reflects the recognition that actual dietary exposure to active enzyme from finished foods is negligible under good manufacturing practices. Therefore, rather than calculating a hypothetical mg per kg body weight intake, it is more appropriate to note that process designs and immobilization strategies limit enzyme presence in end products. To illustrate how ADI calculations normally work for chemical additives with numeric ADIs: if an additive had a hypothetical ADI of X mg per kg body weight per day, a person weighing Y kg would have a daily intake limit of X times Y mg. That figure would then be compared against estimated actual exposure from consumption of foods containing the additive to ensure that exposure remains below the ADI. In the case of enzymes like glucose isomerase used as processing aids, the regulatory condition that they be used in accordance with current good manufacturing practice effectively serves as the control mechanism rather than a numeric daily limit. Thus, while typical ADI example calculations involve body weight and additive concentration, for processing enzymes with negligible dietary presence, narrative explanations of use conditions and process controls replace numeric intake examples. The regulatory requirement that enzyme preparations be derived from nonpathogenic microorganisms and used in controlled conditions safeguards consumer exposure without relying on numeric ADI values.
Safety And Health Research
Safety assessments of glucose isomerase from Streptomyces olivochromogenes focus on the enzyme preparation’s production process and the characteristics of the source microorganism rather than on pharmacological effects in humans. Enzymes used in food processing are evaluated for potential contaminants, allergenicity, and unintended toxicological effects associated with fermentation byproducts or residual cellular material. The use of well-characterized, nonpathogenic strains and downstream processing steps designed to remove unwanted substances are central to safety evaluations. Regulatory inventories reflect the outcome of such assessments in affirming enzyme preparation use under good manufacturing practice conditions. Because glucose isomerase functions as a catalyst during processing and is not intended to remain in finished products at significant levels, exposure to active enzyme in the diet is minimal. Toxicological studies submitted to regulatory bodies typically focus on supporting the safety of production strains and demonstrating that the enzyme preparation does not introduce hazardous substances into food. Reports and monographs from expert committees address enzyme classification, production methods, and specifications for purity and activity, forming part of the evidence base used by regulators to determine acceptable use conditions. Health research on microbial enzymes used in food processing seldom identifies direct biological effects from dietary exposure because enzyme activity requires specific substrates and environmental conditions not found after ingestion. Any potential digestive degradation in the gastrointestinal tract further limits systemic exposure. Regulatory evaluations emphasize manufacturing controls, characterization of raw materials, and absence of pathogenic traits in production organisms. Industry and academic researchers continue to investigate enzyme properties, including structural stability and catalytic kinetics, to optimize processing applications. These studies contribute to understanding enzyme performance but do not typically bear directly on safety in the context of food additive regulation when manufacturing and use conditions meet established standards.
Regulatory Status Worldwide
In the United States, glucose isomerase preparations derived from Streptomyces olivochromogenes, when rendered insoluble and used according to current good manufacturing practice, are listed in the Code of Federal Regulations at 21 CFR 184.1372. This section affirms insoluble glucose isomerase enzyme preparations as direct food substances generally recognized as safe under specified conditions of use, particularly in the production of high fructose corn syrup and similar food processing applications. The regulation states that such preparations must be derived from recognized nonpathogenic and nontoxicogenic microorganisms, including Streptomyces olivochromogenes, and must be used under conditions that do not exceed current good manufacturing practice. This regulatory inclusion reflects evaluation by FDA of the safety of the enzyme preparation’s use in food processing without arbitrary numerical limits on use levels beyond those good manufacturing practice conditions. The citation of the relevant CFR section demonstrates that U.S. regulators have specifically addressed the use of this enzyme preparation within food additive or GRAS frameworks. Internationally, the Joint FAO/WHO Expert Committee on Food Additives (JECFA) evaluated glucose isomerase from Streptomyces olivochromogenes and noted it as a microbial enzyme preparation in its reports. The JECFA evaluation acknowledges the functional class of the enzyme and its specifications for enzyme preparations used in food processing but does not establish a numerical acceptable daily intake (ADI) in the way some chemical additives require because the enzyme preparation is not considered to present the same type of exposure profile as small-molecule additives. This type of enzyme preparation falls into a category of food processing aids that have long-standing use and are understood in context of their catalytic role rather than systemic exposure. Regulatory frameworks in other jurisdictions may adopt similar approaches for enzyme preparations intended for food processing. National food safety agencies generally require evidence of nonpathogenic production strains and conditions that prevent harmful contaminants. The presence of glucose isomerase on enzyme preparation lists and in regulatory inventories reflects a consensus that its use under specified conditions does not pose a safety concern when good manufacturing practices are observed. Globally harmonized codes of practice and international standards for enzyme preparations used in food processing provide additional context for understanding how such ingredients are managed across markets.
Taste And Functional Properties
Glucose isomerase from Streptomyces olivochromogenes itself has minimal sensory impact on food products. Because it is used as an immobilized enzyme preparation and is not meant to contribute flavor or texture directly, its functional properties are tied to its catalytic activity rather than taste. The primary sensory effect associated with its application arises from the result of its catalytic reaction: the increased proportion of fructose relative to glucose in syrup blends. Since fructose is inherently sweeter than glucose, products formulated with fructose-enriched syrups can deliver higher sweetness intensity without increasing total sugar content. This difference in sweetness can influence product formulation choices and sensory outcomes. Functionally, enzyme preparations such as glucose isomerase are engineered to exhibit stability under processing conditions that include varied temperatures and pH ranges. Enzyme activity often peaks at moderate temperatures and near-neutral pH levels typical of sugar conversion processes. Immobilized forms help retain the enzyme within a solid support, permitting reuse and simplifying separation from product streams. This immobilization can also enhance functional stability, allowing repeated cycles of use with less loss of activity compared to free enzyme solutions. Importantly, because glucose isomerase preparations remain insoluble and are used under defined conditions of current good manufacturing practice, residues in finished food products are typically negligible. The enzyme’s role is transient during processing, and its activity does not contribute a discernible direct taste. Manufacturers rely on analytical methods to monitor sugar composition rather than sensory assessment to confirm that the desired conversion has occurred. This distinction reinforces the enzyme’s classification as a processing aid rather than a flavoring agent or nutritive ingredient.
Acceptable Daily Intake Explained
Acceptable Daily Intake (ADI) is a concept used by food safety authorities to express the amount of a substance that can be consumed daily over a lifetime without appreciable health risk. For enzymes like glucose isomerase from Streptomyces olivochromogenes, regulatory evaluations often do not establish a numeric ADI because these preparations are used as processing aids and are not expected to remain in food at measurable levels. Instead, the focus is on conditions of use that ensure that actual dietary exposure to the active enzyme protein or its residues is minimal. Where expert committees evaluate food additives with ADIs, such values are often derived from toxicological studies. In the case of enzyme preparations intended for processing use, such data may not be necessary for regulatory affirmation when evidence supports negligible exposure and lack of hazardous impurities. Safety evaluations for food enzymes consider the nature of the enzyme, the production organism, and the manufacturing process. Because glucose isomerase acts catalytically during processing and is often immobilized, its direct presence in the food that consumers eat is not inherent to its regulatory assessment. Instead of a numeric ADI, regulatory listings define conditions of use, supporting the concept that if the enzyme is used under good manufacturing practice and does not persist in finished products, daily intake is effectively controlled by process design. This approach reflects a risk-based evaluation that considers actual exposure and the function of the ingredient in food production. Consumers should understand that an ADI represents a conservative benchmark derived from safety studies, but for processing aids like enzymes, regulatory frameworks may not assign specific numeric ADIs because exposure is not expected to be significant. The absence of a numeric ADI in regulatory documentation does not imply that the enzyme lacks safety evaluation; rather, it reflects the nature of its use and the assessment outcomes regarding exposure and hazard.
Comparison With Similar Additives
Enzyme preparations used in food processing share functional similarities but differ in catalytic roles and regulatory treatments. For example, lactase enzyme preparations are used to hydrolyze lactose into glucose and galactose in dairy products, aiding digestion for lactose-intolerant consumers. Like glucose isomerase, lactase may be affirmed for food use under specified conditions because its role is catalytic and not nutritive. Other enzymes such as amylases catalyze starch breakdown into simpler sugars and are widely used in baking and sweetener production; these are included in regulatory enzyme inventories with defined functional contexts. Unlike small-molecule flavor enhancers or preservatives that often require numeric acceptable daily intakes, enzymes are assessed based on source strain safety and manufacturing controls because their catalytic role limits direct exposure. Some enzyme preparations, such as proteases used in meat tenderization or brewing, are also immobilized or removed after their processing role has been fulfilled, reinforcing their classification as processing aids. This contrasts with additives like sodium benzoate, which remain in the food matrix and therefore have ADI values to manage chronic dietary exposure. Comparisons among glucose isomerase, lactase, and amylase illustrate a spectrum of catalytic functions in food processing: conversion of glucose to fructose for sweetness, degradation of lactose to support digestibility, and starch hydrolysis to support texture and fermentable sugar formation. Despite functional differences, all share the characteristic that regulatory evaluations focus on production organism safety and use conditions rather than systemic body effects tied to additive residence in finished food products. This risk-based approach aligns assessment strategies with actual exposure scenarios and processing utility.
Common Food Applications Narrative
Glucose isomerase from Streptomyces olivochromogenes finds its primary application in the production of high fructose corn syrup (HFCS) and related fructose-enriched syrups. In broad terms, HFCS and similar products serve as sweetening agents in a wide array of processed foods and beverages. The enzyme’s role is to catalyze the conversion of glucose, a six-carbon aldose sugar, into fructose, its ketose isomer, increasing overall sweetness and enabling product formulations that balance sweetness, stability, and cost. Food categories that commonly incorporate fructose-enriched syrups include soft drinks, fruit-flavored beverages, baked goods, breakfast cereals, confectionery, sauces, and dressings. In these product classes, fructose-rich sweeteners contribute to the overall flavor profile as well as to functional properties related to moisture retention and browning during cooking and baking. Apart from HFCS production, glucose isomerase preparations support the manufacture of other fructose-based sweeteners. These fructose-rich syrups can be blended with other carbohydrate sweeteners or used independently in formulations seeking specific sweetness or textural attributes. The flexibility of enzyme-based conversion means that food processors can tailor sugar profiles to match product objectives, such as sweetness intensity or caloric contribution, while integrating into standardized processing lines. The application of glucose isomerase in food processing is closely associated with large-scale industrial environments. Enzyme reactors designed to facilitate glucose-to-fructose conversion operate using immobilized enzyme preparations that allow continuous processing. By maintaining glucose isomerase within reactors where glucose-rich syrups flow over the immobilized matrix, producers can achieve consistent conversion rates and syrup composition that meet product specifications. This engineering approach enhances efficiency and aligns with best practices in food bioprocessing. Food manufacturers and ingredient suppliers work within regulatory frameworks that define acceptable processing aids and direct food substances. Enzyme preparations like glucose isomerase are included in such frameworks when supported by safety evaluations and affirmed conditions of use. End products sweetened with fructose-enriched syrups undergo their own quality control and labeling processes but need not list processing enzymes that do not remain as intentional components of the final food, provided their use conforms to regulatory expectations for processing aids.
Safety & Regulations
FDA
- Approved: True
- Regulation: 21 CFR 184.1372
EFSA
- Notes: No EFSA numeric ADI available in sources
JECFA
- Notes: JECFA did not specify a numeric ADI
Comments
Please login to leave a comment.
No comments yet. Be the first to share!